It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GMPW’s FA Score shows that 0 FA rating(s) are green whileHBUV’s FA Score has 0 green FA rating(s).
GMPW (@Real Estate Development) experienced а -15.98% price change this week, while HBUV (@Real Estate Development) price change was 0.00% for the same time period.
The average weekly price growth across all stocks in the @Real Estate Development industry was -2.78%. For the same industry, the average monthly price growth was +10.00%, and the average quarterly price growth was +7.89%.
GMPW is expected to report earnings on Apr 18, 2023.
Activities range from the renovation and re-lease of existing buildings to the purchase of raw land and the sale of developed land or parcels to others. Demand for land development business is driven by GDP growth, employment rates, interest rates, and access to/cost of capital. For individual companies in this industry, proper cost estimation and successful bidding play critical roles in their profitability. Large companies could potentially have greater access to capital, while smaller companies can specialize in a specific geographic area or market niche. CBRE Group, VICI Properties Inc and Brookfield Property Partners L.P. are some of the large companies in this industry.
GMPW | HBUV | GMPW / HBUV | |
Capitalization | 1.23M | 26M | 5% |
EBITDA | -90.76K | 1.09M | -8% |
Gain YTD | -17.004 | 2066.667 | -1% |
P/E Ratio | 32.57 | 131.58 | 25% |
Revenue | 490K | 1.6M | 31% |
Total Cash | 2.39K | 88.5K | 3% |
Total Debt | 199K | 16.5M | 1% |
GMPW | HBUV | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 71 Overvalued | 71 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 54 | |
SMR RATING 1..100 | 92 | 100 | |
PRICE GROWTH RATING 1..100 | 39 | 34 | |
P/E GROWTH RATING 1..100 | 82 | 65 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
GMPW's Valuation (71) in the null industry is in the same range as HBUV (71). This means that GMPW’s stock grew similarly to HBUV’s over the last 12 months.
HBUV's Profit vs Risk Rating (54) in the null industry is somewhat better than the same rating for GMPW (100). This means that HBUV’s stock grew somewhat faster than GMPW’s over the last 12 months.
GMPW's SMR Rating (92) in the null industry is in the same range as HBUV (100). This means that GMPW’s stock grew similarly to HBUV’s over the last 12 months.
HBUV's Price Growth Rating (34) in the null industry is in the same range as GMPW (39). This means that HBUV’s stock grew similarly to GMPW’s over the last 12 months.
HBUV's P/E Growth Rating (65) in the null industry is in the same range as GMPW (82). This means that HBUV’s stock grew similarly to GMPW’s over the last 12 months.
RSI ODDS (%) |
Stochastic ODDS (%) |
Momentum ODDS (%) |
MACD ODDS (%) |
TrendWeek ODDS (%) |
TrendMonth ODDS (%) |
Advances ODDS (%) |
Declines ODDS (%) |
BollingerBands ODDS (%) |
Aroon ODDS (%) |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
EWG | 31.58 | 0.04 | +0.13% |
iShares MSCI Germany ETF | |||
UPAR | 13.45 | -0.10 | -0.75% |
UPAR Ultra Risk Parity ETF | |||
OSEA | 26.31 | -0.23 | -0.85% |
Harbor International Compounders ETF | |||
IJK | 93.56 | -1.38 | -1.45% |
iShares S&P Mid-Cap 400 Growth ETF | |||
FTXH | 27.10 | -0.89 | -3.18% |
First Trust Nasdaq Pharmaceuticals ETF |
A.I.dvisor tells us that GMPW and MGAWY have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GMPW and MGAWY's prices will move in lockstep.
Ticker / NAME | Correlation To GMPW | 1D Price Change % | ||
---|---|---|---|---|
GMPW | 100% | -15.98% | ||
MGAWY - GMPW | 22% Poorly correlated | N/A | ||
HBUV - GMPW | 13% Poorly correlated | N/A | ||
GRNNF - GMPW | 12% Poorly correlated | N/A | ||
FHRT - GMPW | 12% Poorly correlated | N/A | ||
HGPI - GMPW | 1% Poorly correlated | N/A | ||
More |
A.I.dvisor indicates that over the last year, HBUV has been loosely correlated with FHRT. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if HBUV jumps, then FHRT could also see price increases.
Ticker / NAME | Correlation To HBUV | 1D Price Change % | ||
---|---|---|---|---|
HBUV | 100% | N/A | ||
FHRT - HBUV | 62% Loosely correlated | N/A | ||
GYRO - HBUV | 28% Poorly correlated | -0.50% | ||
SWPFF - HBUV | 21% Poorly correlated | N/A | ||
AZLCZ - HBUV | 20% Poorly correlated | -3.13% | ||
MDJH - HBUV | 20% Poorly correlated | -0.83% | ||
More |